Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke

References

• Lindemann S, Krämer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007; 5(Suppl. 1)203–211
   PubMedGoogle Scholar
• Hu H, Zhu L, Huang Z, Ji Q, Chatterjee M, Zhang W, Li N. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus. Thromb Haemost 2010; 104: 1184–1192
   PubMed Web of Science ®Google Scholar
• Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357: 2482–2494
   PubMed Web of Science ®Google Scholar
• Jurk K, Ritter MA, Schriek C, Van Aken H, Droste DW, Ringelstein EB, Kehrel BE. Activated monocytes capture platelets for heterotypic association in patients with severe carotid artery stenosis. Thromb Haemost 2010; 103: 1193–1202
   PubMedGoogle Scholar
• McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997; 100: 485–492
   PubMed Web of Science ®Google Scholar
• Jennings LK. Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009; 102: 248–257
   PubMed Web of Science ®Google Scholar
• Michelson AD, Barnard MR, Hechtman H, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877–11883
   PubMed Web of Science ®Google Scholar
• Anand SX, Viles-Gonzalez JF, Badimon JJ, Cavusoglu E, Marmur JD. Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb Haemost 2003; 90: 377–384
   PubMed Web of Science ®Google Scholar
• Mirlashari MR, Ryningen A, Mikkelsen HM, Fukami MH. Differential secretion of blood platelet storage granules. Platelets 1996; 7: 313–320
   PubMed Web of Science ®Google Scholar
• Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, Mayer H, Grau AJ. Course of platelet activation markers after ischemic stroke. Stroke 2002; 33: 2570–2574
   PubMed Web of Science ®Google Scholar
• Grau AJ, Reiners S, Lichy C, Buggle F, Ruf A. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: A case-crossover study. Stroke 2003; 34: 849–854
   PubMed Web of Science ®Google Scholar
• Garlichs CD, Kozina S, Fateh-Moghadam S, Handschu R, Tomandl B, Stumpf C, Eskafi S, Raaz D, Schmeisser A, Yilmaz A, et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003; 34: 1412–1418
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Malinin AI, Oshrine BR, Sane DC, Takserman A, Atar D, Hennekens CH. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res 2004; 113: 197–204
   PubMed Web of Science ®Google Scholar
• Fateh-Moghadam S, Htun P, Tomandl P, Sander D, Stellos K, Geisler T, Langer H, Walton K, Handschu R, Garlichs C, et al. Hyperresponsiveness of platelets in ischemic stroke. Thromb Haemost 2007; 97: 974–978
   PubMed Web of Science ®Google Scholar
• McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004; 125: 777–787
   PubMed Web of Science ®Google Scholar
• Cha JK, Jeong MH, Jang JY, Bae HR, Lim YJ, Kim JS, Kim SH, Kim JW. Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke: A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis 2003; 16: 376–382
   PubMedGoogle Scholar
• Marquardt L, Anders C, Buggle F, Palm F, Hellstern P, Grau AJ. Leukocyte-platelet aggregates in acute and subacute ischemic stroke. Cerebrovasc Dis 2009; 28: 276–282
   PubMed Web of Science ®Google Scholar
• Yip HK, Chen SS, Liu JS, Chang HW, Kao YF, Lan MY, Chang YY, Lai SL, Chen WH, Chen MC. Serial changes in platelet activation in patients after ischemic stroke: Role of pharmacodynamic modulation. Stroke 2004; 35: 1683–1687
   PubMed Web of Science ®Google Scholar
• Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41
   PubMed Web of Science ®Google Scholar
• Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521–1526
   PubMed Web of Science ®Google Scholar
• Lukasik M, Rozalski M, Luzak B, Michalak S, Watala C, Kozubski W. Platelet activation and reactivity in the convalescent phase of ischaemic stroke. Thromb Haemost 2010; 103: 644–650
   PubMed Web of Science ®Google Scholar
• Jurk K, Jahn U-R, Van Aken H, Schriek C, Droste DW, Ritter MA, Bernd Ringelstein E, Kehrel BE. Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1). Thromb Haemost 2004; 91: 334–344
   PubMed Web of Science ®Google Scholar
• Michelson AD, Barnard MS, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Circulation 2001; 104: 1533–1537
   PubMed Web of Science ®Google Scholar
• Henn V, Steibach S, Buchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047–1054
   PubMed Web of Science ®Google Scholar
• Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation by outside-in signalling. Proc Natl Acad Sci USA 2003; 100: 12367–12371
   PubMedGoogle Scholar
• Aukrust P, Damas JK, Solum NO. Soluble CD40 ligand and platelets: Self-perpetuating pathogenic loop in thrombosis and inflammation?. J Am Coll Cardiol 2004; 43: 2326–2328
   PubMed Web of Science ®Google Scholar
• Choudhury A, Chung I, Panja N, Patel J, Lip GY. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation. Chest 2008; 134: 574–581
   PubMed Web of Science ®Google Scholar
• Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinger AL, 3rd, Michelson AD. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004; 43: 2319–2325
   PubMed Web of Science ®Google Scholar
• Woollard KJ, Kling D, Kulkarni S, Dart AM, Jackson S, Chin-Dusting J. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res 2006; 98: 149–156
   PubMed Web of Science ®Google Scholar
• Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005; 13: 1590–1596
   Google Scholar
• del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604–1611
   PubMed Web of Science ®Google Scholar
• Wang HB, Wang JT, Zhang L, Geng ZH, Xu WL, Xu T, Huo Y, Zhu X, Plow EF, Chen M, et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 2007; 8: 882–892
   PubMed Web of Science ®Google Scholar
• Blann AD, Tan KT, Tayebjee MH, Davagnanam I, Moss M, Lip GY. Soluble CD40L in peripheral artery disease: Relationship with disease severity, platelet markers and the effects of angioplasty. Thromb Haemost 2005; 93: 578–583
   PubMedGoogle Scholar
• Choudhury A, Chung I, Blann AD, Lip GYH. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation. J Am Coll Cardiol 2007; 49: 1957–1964
   PubMed Web of Science ®Google Scholar
• Riondino S, Martini F, La Farina F, Spila A, Guadagni F, Ferroni P. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions. Clin Biochem 2010; 43: 666–670
   PubMed Web of Science ®Google Scholar
• Lim SM, Blann AD, Lip GYH. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus. Circulation 2004; 109: 2524–2528
   PubMed Web of Science ®Google Scholar
• Cao Y-J, Wang Y-M, Zhang J, Zeng YJ, Liu CF. The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction. J Thromb Thrombolysis 2009; 27: 233–238
   PubMedGoogle Scholar
• Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, Huang CR, Chen SD, Chuang YC, Lee LH, Wang HC, et al. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Thromb Res 2009; 124: 213–218
   PubMed Web of Science ®Google Scholar